Usefulness of lactate dehydrogenase and serum C-reactive protein in the follow-up of patients with lung transplantation
S. Hermoso De Mendoza Aristegui (Palma de Mallorca, Spain), L. Ramón (Palma de Mallorca, Spain), C. Suárez (Palma de Mallorca, Spain), C. Bravo (Barcelona, Spain), C. Berastegui (Barcelona, Spain), J. Sauleda (Palma de Mallorca, Spain), E. Sala (Palma de Mallorca, Spain), F. Verdú (Palma de Mallorca, Spain)
Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Hermoso De Mendoza Aristegui (Palma de Mallorca, Spain), L. Ramón (Palma de Mallorca, Spain), C. Suárez (Palma de Mallorca, Spain), C. Bravo (Barcelona, Spain), C. Berastegui (Barcelona, Spain), J. Sauleda (Palma de Mallorca, Spain), E. Sala (Palma de Mallorca, Spain), F. Verdú (Palma de Mallorca, Spain). Usefulness of lactate dehydrogenase and serum C-reactive protein in the follow-up of patients with lung transplantation. 4730
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011
Usefulness of troponin-1, lactate and c-reactive protein as a prognostic markers in critically ill, non cardiac patients Source: Eur Respir J 2005; 26: Suppl. 49, 436s Year: 2005
Usefulness of troponin-I, lactate, C-reactive protein as a prognostic markers in critically ill non-cardiac patients Source: Eur Respir J 2006; 28: Suppl. 50, 181s Year: 2006
Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012
Serum leptin, insulin and C-reactive protein (CRP) in patients with pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006
Level of C-reactive protein in blood serum of patients with MDR tuberculosis before and after treatment Source: Eur Respir J 2007; 30: Suppl. 51, 201s Year: 2007
Prognostic role of serum gamma-glutamyl transferase levels in patients with pulmonary thromboembolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011
Procalcitonin and C-reactive protein levels correlate worse with organ failure than NT-proBNP levels in septic patients Source: Eur Respir J 2006; 28: Suppl. 50, 61s Year: 2006
Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008
The relation of serum interleukin-6 and C-reactive protein to clinical parameters in pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 35s Year: 2004
Lactate dehydrogenase as a biomarker in brochoalveolar lavage of patients with lung cancer Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009
Association between C-reactive protein levels and outcome in acute lung injury in children Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care Year: 2011
CEA levels in the serum and induced sputum of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005
Evaluation of serum levels of Sirtuin-1 in lung cancer patients Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020
The predictive prognostic role of elevated blood d-dimer and blood lactate in severe sepsis patients Source: Annual Congress 2009 - Acute lung injury and biomarkers Year: 2009
Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis? Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004
Serum neopterin and IL-6 as biomarkers in patients with COPD. Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017
The study on the association of serum C-reactive protein level with the risk of lung cancer Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009
The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010
Serum lipid levels in patients with bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008